BCWORLD PHARM. Co. Ltd
BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberc… Read more
BCWORLD PHARM. Co. Ltd (200780) - Total Assets
Latest total assets as of September 2025: ₩173.79 Billion KRW
Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) holds total assets worth ₩173.79 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BCWORLD PHARM. Co. Ltd - Total Assets Trend (2015–2024)
This chart illustrates how BCWORLD PHARM. Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BCWORLD PHARM. Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
BCWORLD PHARM. Co. Ltd's total assets of ₩173.79 Billion consist of 25.3% current assets and 74.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩5.44 Billion | 0.0% |
| Accounts Receivable | ₩20.34 Billion | 11.5% |
| Inventory | ₩14.84 Billion | 8.4% |
| Property, Plant & Equipment | ₩120.98 Billion | 68.6% |
| Intangible Assets | ₩2.71 Billion | 1.5% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2015–2024)
This chart illustrates how BCWORLD PHARM. Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BCWORLD PHARM. Co. Ltd's current assets represent 25.3% of total assets in 2024, a decrease from 38.2% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 5.4% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 68.6% of total assets.
BCWORLD PHARM. Co. Ltd Competitors by Total Assets
Key competitors of BCWORLD PHARM. Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Novartis AG
PINK:NVSEF
|
USA | $115.49 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $208.73 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $133.96 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $29.44 Billion |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
BCWORLD PHARM. Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - BCWORLD PHARM. Co. Ltd generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BCWORLD PHARM. Co. Ltd is currently not profitable relative to its asset base.
BCWORLD PHARM. Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.52 | 0.48 | 0.97 |
| Quick Ratio | 0.30 | 0.29 | 0.50 |
| Cash Ratio | 0.00 | 0.06 | 0.00 |
| Working Capital | ₩-41.34 Billion | ₩ -42.06 Billion | ₩ -1.83 Billion |
BCWORLD PHARM. Co. Ltd - Advanced Valuation Insights
This section examines the relationship between BCWORLD PHARM. Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.71 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.2% |
| Total Assets | ₩176.31 Billion |
| Market Capitalization | $19.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values BCWORLD PHARM. Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: BCWORLD PHARM. Co. Ltd's assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for BCWORLD PHARM. Co. Ltd (2015–2024)
The table below shows the annual total assets of BCWORLD PHARM. Co. Ltd from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩176.31 Billion | -4.24% |
| 2023-12-31 | ₩184.11 Billion | +0.58% |
| 2022-12-31 | ₩183.05 Billion | +2.06% |
| 2021-12-31 | ₩179.36 Billion | -7.05% |
| 2020-12-31 | ₩192.96 Billion | +11.68% |
| 2019-12-31 | ₩172.78 Billion | +6.82% |
| 2018-12-31 | ₩161.74 Billion | +36.67% |
| 2017-12-31 | ₩118.34 Billion | +22.73% |
| 2016-12-31 | ₩96.42 Billion | +21.50% |
| 2015-12-31 | ₩79.36 Billion | -- |